糖基化
糖蛋白
计算生物学
硼酸
生物标志物
纳米技术
计算机科学
生物分子
化学
生物传感器
生化工程
翻译生物信息学
蛋白质组学
临床诊断
生物标志物发现
疾病
人类疾病
生物相容性材料
灵敏度(控制系统)
作者
Roberto María Hormigos,Olga Monago‐Maraña,Agustín G. Crevillén
出处
期刊:Chemosensors
[Multidisciplinary Digital Publishing Institute]
日期:2026-02-03
卷期号:14 (2): 38-38
被引量:4
标识
DOI:10.3390/chemosensors14020038
摘要
Aberrant glycosylation is linked to several diseases, making glycoproteins and their glycoforms promising biomarkers. Traditional methods like mass spectrometry offer high sensitivity but are costly, time-consuming, and unsuitable for point-of-care testing. Electrochemical biosensors emerge as an attractive alternative due to their simplicity, affordability, portability, and rapid response. This review focuses on electrochemical strategies developed to assess the glycosylation level of a specific glycoprotein or biological structure rather than merely glycoprotein or cell concentration, as in previous reviews. Approaches include the use of aptamers, boronic acid derivatives, antibodies, and lectins, often combined with nanomaterials for enhanced sensitivity. Applications span the diagnosis/prognosis of several illnesses such as diabetes, congenital disorders of glycosylation, cancer, and neurodegenerative diseases. Innovative designs incorporate microfluidic and paper-based platforms for faster, low-cost analysis, while strategies using dual-signal acquisition or competitive assays improve accuracy. Despite promising sensitivity and selectivity, most sensors require multi-step protocols and lack of validation in clinical samples. Future research should focus on simplifying procedures, integrating microfluidics, and exploring novel capture or detection probes such as metal complexes or metal–organic frameworks. Overall, electrochemical sensors hold significant potential for point-of-care testing, enabling rapid and precise evaluation of glycosylation status, which could drive cell-based biomarker discovery and disease diagnostics.
科研通智能强力驱动
Strongly Powered by AbleSci AI